Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of F373280

This study has been terminated.
Information provided by (Responsible Party):
Pierre Fabre Medicament Identifier:
First received: April 11, 2013
Last updated: October 20, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)